浙里管
Description
浙里管（患者端）APP是专注于慢性病领域的专业智能管理平台。与医院合作，致力于为慢性病患者提供院内外一体化健康管理服务。帮助您快捷记录血糖、血压，使用HealthKit工具获取日常活动步数，形成日常健康指标体系，随时掌握个人健康情况，永久保存，随时调用；轻松联系您的专属医生在线问诊，为您提供专业建议帮助您回归健康生活。
Screenshots
浙里管 FAQ
-
Is 浙里管 free?
Yes, 浙里管 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 浙里管 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 浙里管 cost?
浙里管 is free.
-
What is 浙里管 revenue?
To get estimated revenue of 浙里管 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Sweden yet.
Ratings History
浙里管 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
浙里管 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
碧海慢病管理
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
高血压大夫（患者版）——全国高血压智能管理平台
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
圆爱康用户端
家用盆底测评训练
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
皮科联盟
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
移路同行医生版
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
西京诊疗平台医生端
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
CKDcloud
|
Unlock
|
Unlock
|
0
|
|
4 years ago | |
N/A
N/A
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
南风医生医师版2.0
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
南风医生药师版2.0
|
Unlock
|
Unlock
|
0
|
|
2 years ago |
浙里管 Installs
Last 30 days
浙里管 Revenue
Last 30 days浙里管 Revenue and Downloads
Gain valuable insights into 浙里管 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- Chinese
- Recent release
- 3.0.0 (1 year ago )
- Released on
- Oct 20, 2020 (4 years ago )
- Also available in
- Poland , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , Italy , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , India
- Last Updated
- 2 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.